Literature DB >> 26261603

Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China.

Yun-Fei Shi1, Xiang-Hong Li1, Yu-Qin Song2, Wei-Wei Song2, Yu-Mei Lai1.   

Abstract

OBJECTIVES: This study aimed to evaluate key features of bone marrow trephine biopsy (BMT) involvement of lymphoma in Northern China.
METHODS: 950 cases were assessed for the occurrence of bone marrow involvement and architectural features including volume percentage, involvement pattern (diffuse, nodular, focal, para trabecular, or interstitial), and presence/absence of background changes (granuloma, stromal fibrosis or necrosis). Correlations with bone marrow aspirate (BMA) and flow cytometry (FCM) findings were made in a subset of paired cases (359 BMA and 364 FCM).
RESULTS: 153 (16.1%) cases involved BMT. The most frequent type was mantle cell lymphoma (28/153, 18.3%). Architectural features were similar to previous studies except that diffuse large B-cell lymphoma (DLBCL) preferred focal pattern (16/22 cases, 72.7%) most of all. BMA and BMT agreed in 84.1% of cases (302 of 359: 277 both negative, 25 both positive), while FCM and BMT agreed in 80.8% of cases (294 of 364: 242 both negative, 52 both positive). Both varied widely among different subgroups.
CONCLUSIONS: Occurrence of BMT involvement by lymphoma in Northern China is relatively low. The volume percentage, distribution patterns and background changes may be useful pointers towards a particular lymphoma type in Chinese. FCM is more sensitive and reliable than BMA in China.

Entities:  

Keywords:  Chinese; Lymphoma; bone marrow; involvement; pathology

Mesh:

Substances:

Year:  2015        PMID: 26261603      PMCID: PMC4525937     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  Incidence and histological features of bone marrow involvement in malignant lymphomas.

Authors:  G Lambertenghi-Deliliers; C Annaloro; D Soligo; A Oriani; E Pozzoli; N Quirici; R Luksch; E E Polli
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

Review 2.  Bone marrow biopsy in Hodgkin's lymphoma.

Authors:  Vito Franco; Claudio Tripodo; Aroldo Rizzo; Mario Stella; Ada Maria Florena
Journal:  Eur J Haematol       Date:  2004-09       Impact factor: 2.997

3.  Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens.

Authors:  Daniel A Arber; Tracy I George
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

4.  Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

Authors:  M G Conlan; M Bast; J O Armitage; D D Weisenburger
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

5.  Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.

Authors:  J Thiele; T K Zirbes; H M Kvasnicka; R Fischer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

Review 6.  Bone marrow involvement by hodgkin and non-hodgkin lymphomas.

Authors:  Qian-Yun Zhang; Kathryn Foucar
Journal:  Hematol Oncol Clin North Am       Date:  2009-08       Impact factor: 3.722

7.  Evaluation of bone marrow in 143 lymphomas: the relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validity.

Authors:  Tarek M N El Bolkainy; Wael S Abo Deif; Heba M Gouda; Nadia M Mokhtar
Journal:  J Egypt Natl Canc Inst       Date:  2008-03

Review 8.  Back to the thymus: peripheral T cells come home.

Authors:  J Scott Hale; Pamela J Fink
Journal:  Immunol Cell Biol       Date:  2008-11-25       Impact factor: 5.126

9.  Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.

Authors:  Hongyan Tong; Yanling Ren; Wenbin Qian; Feng Xiao; Wenyuan Mai; Haitao Meng; Jie Jin
Journal:  Int J Hematol       Date:  2009-09-02       Impact factor: 2.490

10.  Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution.

Authors:  Qun-Pei Yang; Wen-Yan Zhang; Jian-Bo Yu; Sha Zhao; Huan Xu; Wei-Ya Wang; Cheng-Feng Bi; Zhuo Zuo; Xiao-Qing Wang; Juan Huang; Lin Dai; Wei-Ping Liu
Journal:  Diagn Pathol       Date:  2011-08-22       Impact factor: 2.644

View more
  4 in total

1.  DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement.

Authors:  Junhua Mai; Xin Li; Guodong Zhang; Yi Huang; Rong Xu; Qi Shen; Ganesh L Lokesh; Varatharasa Thiviyanathan; Lingxiao Chen; Haoran Liu; Youli Zu; Xiaojing Ma; David E Volk; David G Gorenstein; Mauro Ferrari; Haifa Shen
Journal:  Mol Pharm       Date:  2018-03-26       Impact factor: 4.939

2.  Diffuse large B-cell lymphoma: morphologic and immunohistochemical analysis of bone marrow for staging, with emphasis on lymphoid aggregates.

Authors:  Vinicius C Nóbrega; Maria A C Domingues; Lígia Niero-Melo; Cristiano C Oliveira
Journal:  Int J Clin Exp Pathol       Date:  2022-09-15

3.  Ureteric lymphoma as a rare cause of right lower ureteric obstruction.

Authors:  Jayaram Sreenivas; Ashwin Mallya; Vilvapathy Senguttuvan Karthikeyan; Usha Amirtham
Journal:  BMJ Case Rep       Date:  2016-01-29

4.  How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution.

Authors:  Woo-Jae Kwoun; Jeong-Yeal Ahn; Pil-Whan Park; Yiel-Hea Seo; Kyung-Hee Kim; Ja Young Seo; Hwan Tae Lee; Kuai-Han Yoo
Journal:  J Clin Lab Anal       Date:  2019-02-06       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.